# IBERE PHARMACEUTICALS (IBERWS)

> Institutional ownership reported to the SEC as of Q1 2023, from Form 13F filings. Source: https://holderbook.com/stocks/IBERWS/

- Reporting holders: 1
- Reported value: $108.1K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Lynwood Capital Management Inc.](https://holderbook.com/funds/1846412-lynwood-capital-management-inc/) | $108.1K | 9,800 | 0.1% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2023 | 1 | $108.1K |
| Q4 2022 | 32 | $2.3M |
| Q3 2022 | 37 | $2.7M |
| Q2 2022 | 35 | $2.5M |
| Q1 2022 | 31 | $2.8M |
| Q4 2021 | 28 | $3.8M |
| Q3 2021 | 21 | $3.6M |
| Q2 2021 | 19 | $3.7M |